While the NPR piece frames U.S. passenger rerouting from Ebola zones as a logistical shift, it misses how such restrictions amplify personal dread without bolstering actual safety, a pattern rooted in the 2014 epidemic. Observational data from that period, including cohort analyses of over 1,200 travelers (no RCTs feasible amid crisis), showed travel limits delayed spread minimally yet spiked anxiety and stigma, per a Lancet Infectious Diseases review with no major pharma conflicts. CDC guidelines from the era, cross-referenced with WHO observational reports on 500+ cases, highlighted policy emphasis on optics rather than transmission modeling. This rerouting lens reveals overlooked connections to wellness erosion via heightened traveler stress, where fear itself becomes a secondary public health vector unaddressed in surface coverage.